APA (7th ed.) Citation

3rd, M. F., & WH, S. (1997). Rationale for early treatment with interferon beta-1a in relapsing-remitting multiple sclerosis. Clinical therapeutics, 19(5), 868. https://doi.org/10.1016/s0149-2918(97)80041-0

Chicago Style (17th ed.) Citation

3rd, Munschauer FE, and Stuart WH. "Rationale for Early Treatment with Interferon Beta-1a in Relapsing-remitting Multiple Sclerosis." Clinical Therapeutics 19, no. 5 (1997): 868. https://doi.org/10.1016/s0149-2918(97)80041-0.

MLA (9th ed.) Citation

3rd, Munschauer FE, and Stuart WH. "Rationale for Early Treatment with Interferon Beta-1a in Relapsing-remitting Multiple Sclerosis." Clinical Therapeutics, vol. 19, no. 5, 1997, p. 868, https://doi.org/10.1016/s0149-2918(97)80041-0.